249 related articles for article (PubMed ID: 23664125)
41. [Risk behaviors of intravenous drug users: are females taking more risks of HIV and HCV transmission?].
Vidal-Trécan G; Coste J; Coeuret M; Delamare N; Varescon-Pousson I; Boissonnas A
Rev Epidemiol Sante Publique; 1998 Jun; 46(3):193-204. PubMed ID: 9690286
[TBL] [Abstract][Full Text] [Related]
42. Sexual mixing and condom use with different types of sex partners among non-institutionalized sexually active female injecting drug users in Sichuan, China.
Lau JT; Tsui HY; Gu J; Zhang J; Zhang L; Zhang Y; Cheng F; Wang N
AIDS Behav; 2011 Jan; 15(1):86-94. PubMed ID: 20625925
[TBL] [Abstract][Full Text] [Related]
43. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
[TBL] [Abstract][Full Text] [Related]
44. Sexual activity as a risk factor for hepatitis C in Puerto Rico.
De Jesús-Caraballo J; Toro DH; Rodríguez-Pérez F; Ruiz H; Dueño MI; Alvarez M; Suárez-Pérez E;
Bol Asoc Med P R; 2008; 100(3):15-20. PubMed ID: 19227710
[TBL] [Abstract][Full Text] [Related]
45. Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.
Roy KM; Goldberg DJ; Hutchinson S; Cameron SO; Wilson K; MacDonald L
J Med Virol; 2004 Sep; 74(1):62-6. PubMed ID: 15258969
[TBL] [Abstract][Full Text] [Related]
46. Association between injection in public places and HIV/HCV risk behavior among people who use drugs in Ukraine.
Mazhnaya A; Tobin KE; Owczarzak J
Drug Alcohol Depend; 2018 Aug; 189():125-130. PubMed ID: 29913323
[TBL] [Abstract][Full Text] [Related]
47. Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993.
Hunter GM; Donoghoe MC; Stimson GV; Rhodes T; Chalmers CP
AIDS; 1995 May; 9(5):493-501. PubMed ID: 7639975
[TBL] [Abstract][Full Text] [Related]
48. Knowledge of status and assessment of personal health consequences with hepatitis C are not enough to change risk behaviour among injecting drug users in Stockholm County, Sweden.
Norden L; Saxon L; Kåberg M; Käll K; Franck J; Lidman C
Scand J Infect Dis; 2009; 41(10):727-34. PubMed ID: 19688640
[TBL] [Abstract][Full Text] [Related]
49. Sexual and injecting risk behaviours among regular ecstasy users.
Dunn M; Day C; Bruno R; Degenhardt L; Campbell G
Addict Behav; 2010 Feb; 35(2):157-60. PubMed ID: 19781861
[TBL] [Abstract][Full Text] [Related]
50. Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.
Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J;
Int J Drug Policy; 2015 Oct; 26(10):976-83. PubMed ID: 26115881
[TBL] [Abstract][Full Text] [Related]
51. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities.
Thiede H; Hagan H; Campbell JV; Strathdee SA; Bailey SL; Hudson SM; Kapadia F; Garfein RS;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S39-47. PubMed ID: 17466464
[TBL] [Abstract][Full Text] [Related]
52. Perceived barriers to safe-injection practices among drug injectors who remain HCV-negative.
Stein MD; Dubyak P; Herman D; Anderson BJ
Am J Drug Alcohol Abuse; 2007; 33(4):517-25. PubMed ID: 17668337
[TBL] [Abstract][Full Text] [Related]
53. Indications of immune protection from hepatitis C infection.
Aitken CK; Bowden S; Hellard M; Crofts N
J Urban Health; 2004 Mar; 81(1):58-60. PubMed ID: 15047784
[TBL] [Abstract][Full Text] [Related]
54. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study).
Evans JL; Hahn JA; Page-Shafer K; Lum PJ; Stein ES; Davidson PJ; Moss AR
J Urban Health; 2003 Mar; 80(1):137-46. PubMed ID: 12612103
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.
Rhodes T; Platt L; Maximova S; Koshkina E; Latishevskaya N; Hickman M; Renton A; Bobrova N; McDonald T; Parry JV
Addiction; 2006 Feb; 101(2):252-66. PubMed ID: 16445554
[TBL] [Abstract][Full Text] [Related]
56. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
[TBL] [Abstract][Full Text] [Related]
57. Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico.
Abadie R; Welch-Lazoritz M; Gelpi-Acosta C; Reyes JC; Dombrowski K
Harm Reduct J; 2016 Mar; 13():10. PubMed ID: 26956029
[TBL] [Abstract][Full Text] [Related]
58. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.
Zamani S; Radfar R; Nematollahi P; Fadaie R; Meshkati M; Mortazavi S; Sedaghat A; Ono-Kihara M; Kihara M
Int J Drug Policy; 2010 Nov; 21(6):493-500. PubMed ID: 20483578
[TBL] [Abstract][Full Text] [Related]
59. A certain fate: spread of HIV among young injecting drug users in Manipur, north-east India.
Eicher AD; Crofts N; Benjamin S; Deutschmann P; Rodger AJ
AIDS Care; 2000 Aug; 12(4):497-504. PubMed ID: 11091782
[TBL] [Abstract][Full Text] [Related]
60. Distributive syringe sharing among young adult injection drug users in five U.S. cities.
Golub ET; Strathdee SA; Bailey SL; Hagan H; Latka MH; Hudson SM; Garfein RS;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S30-8. PubMed ID: 17398039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
